Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Neuropharmacology. 2014 Aug 5;86:219–227. doi: 10.1016/j.neuropharm.2014.07.014

Fig. 6. MJ-66 increases Chk2/Cdk1/cyclin B1 activity and phosphorylation of BAD in C6 glioma cells.

Fig. 6

A & B. C6 glioma cells were treated with MJ-66 (60 nM) or vehicle (DMSO) for indicated times and cell lysates were blotted with Chk2 pT68, Cyclin B1, Cdk1 pY15 and Cdk1. C & D. C6 glioma cells were treated with MJ-66 (60 nM) or vehicle (DMSO) for indicated times and cell lysates were blotted with BAD pS112 and BAD.*p < 0.05, **p < 0.01, ***p < 0.001 vs. DMSO.